25 Aug Propeller, GSK Expand Collaboration
Propeller Health has extended its 2015 collaboration with GlaxoSmithKline (GSK) to improve management of asthma and COPD, the company announced recently.
“We are excited to be working closely with GSK to make the sensor for the ELLIPTA inhaler available in our commercial programs, and for the first time, as part of commercial pilots with GSK outside the US,” Propeller CEO David Van Sickle said in a statement.
Sorry, the comment form is closed at this time.